Key Takeaways from ESMO GI 2025 on Pancreatic Cancer
Promising new therapies are emerging. Daraxonrasib, a KRAS-targeting pill, is in Phase 3 trials after earlier encouraging results and FDA Breakthro...
DiCE Grants — Autumn 2025
DiCE opens Autumn 2025 grants: unrestricted operational support for Full and Associate Members, plus the €5,000 Wolfram Nolte Memorial Award for ...
VOICE: A Life-Changing Training in Cancer Research
Patient advocates joined VOICE in London for a week of immersive learning at Barts Cancer Institute. Exploring cancer biology, research methods, an...
EU-CIP Project Launches to Improve Access to Cancer Information Across Europe
The EU-CIP project launched on 12–13 June in Berlin. This EU-funded initiative will provide clear, reliable cancer information for patients, fami...
Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights
Phase III PANOVA-3 trials show that Tumour-Treating Fields Improve Overall Survival Final data from the Phase 3 PANOVA-3 study of tumour treating f...
Amplifying the Patient Voice: Reflections from the WECAN Academy 2025
DiCE Patient Ambassador Mila Ogalla Toledo shares her experience at the WECAN Academy 2025 in Rome—a three-day training for cancer advocates acro...
AIDA Project Uses Artificial Intelligence to Improve Treatment for a Common Cause of Gastric Cancer
The AIDA project has developed an AI system that helps doctors choose more effective treatments for H. pylori, a major cause of gastric cancer. Bas...
A Decade of Learning and Advocacy: 10th DiCE Masterclass in Barcelona
From 2–4 July 2025, Digestive Cancers Europe celebrated a significant milestone with the 10th edition of the DiCE Masterclass. Held in Barcelona,...
From Plans to Patients: Are EU Cancer Screening and NCD Policies Delivering?
Are EU cancer screening and prevention policies truly reaching patients? We assess the progress of Europe’s Beating Cancer Plan and the SANT Comm...
Putting Early-Onset Colorectal Cancer on the Map: A Milestone Moment at ESMO GI 2025
At ESMO GI 2025, patient advocate Michael Kecht delivered his first international talk, highlighting the alarming rise in early‑onset colorectal ...